NYSE · OPHTHALMIC GOODS · LARGE CAP
Bausch & Lomb Corp. BLCO
6 fiscal years on record · USD · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in Bausch & Lomb Corp's annual report to the U.S. Securities and Exchange Commission, filed 18 February 2026. Every sentence was checked against that document before publication.
Growth
USD 5.1B
Revenue, FY2025 · full 6-year series below
Revenue $B
Net income $B
FY2025 · Revenue 5.1 · Net income -0.4
Compound annual growth
Revenue compounded at +8.4% a year over five years.
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−7 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating 2.2% · Net -6.9%
ROE
FY2025 · ROE -5.6%
Each USD of equity lost 6 cents this year.
The 6-year record
6 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Revenue $B | 5.1 | 4.8 | 4.1 | 3.8 | 3.8 | 3.4 |
| Operating income $B | 0.1 | 0.2 | 0.1 | 0.2 | 0.3 | 0.3 |
| EBITDA $B | 0.3 | 0.3 | 0.3 | 0.3 | 0.5 | 0.4 |
| Income tax $B | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 |
| Net income $B | −0.4 | −0.3 | −0.3 | 0.0 | 0.2 | −0.0 |
| Free cash flow $B | −0.1 | −0.1 | −0.2 | 0.2 | 0.7 | 0.3 |
| EPS, diluted $ | −1.02 | −0.90 | −0.74 | 0.02 | 0.52 | −0.05 |
| Dividend / sh $ | · | · | · | · | · | · |
| Payout % | · | · | · | · | · | · |
| ROE % | −5.6 | −4.8 | −3.7 | 0.1 | 2.0 | · |
| Shares out B | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | · |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Provenance
Company facts, as filed
How we verify · 0 failures in 22 reconciliationsAUDITED
Reconciled in 6 of 19 fiscal years. 54 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityOphthalmic Goods
Listed onNYSE
Incorporated innot stated in the filings
Fiscal year endsDecember 31
Data on record since2020